Table 7.
Comparison in passing rates (%) among RTQA2‐measured and TPS‐calculated dose distributions and MatriXX dose distributions with “entire correction” for IMRT (iPlan MC) and VMAT (Eclipse AAA) plans. Gamma evaluation was performed with 3% dose difference and 3 mm DTA.
Plan No. | RTQA2 and TPS | RTQA2 and MatriXX | MatriXX and TPS |
---|---|---|---|
1 (VMAT) | 95.7 | 96.1 | 98.6 |
2 (VMAT) | 98.5 | 94.6 | 99.1 |
3 (IMRT) | 96.0 | 95.4 | 99.8 |
4 (IMRT) | 96.0 | 95.8 | 99.2 |
5 (IMRT) | 97.3 | 95.5 | 95.4 |
6 (IMRT) | 96.6 | 94.8 | 99.6 |